BERRYLAW recognized in 2022 in the ranking of law firms in development capital and LBO whose majority of transactions concern companies under 50 million euros
Ranking 2024 | Health, Pharma & Biotechnology / Capital transactions, joint ventures and corporate ventures
The Health, Pharma & Biotechnology team ranked ‘Excellent’ in the 2024 ranking Capital transactions, joint ventures and corporate transactions.